EUVIMEDEUVIMED entdecken
Leserbrief

Letter: Clonidine Hydrochloride Extended-Release Oral Suspension for Pediatric Attention-Deficit/Hyperactivity Disorder: A Meaningful Addition to Clinical Practice?

Maryam Tariq iD, Ann Genovese

Journal of Child and Adolescent Psychopharmacology · 01.08.2026 · 36 (6) · 384-385

DOI: 10.1177/10445463261454151 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Child and Adolescent Psychopharmacology, online erschienen am 20.05.2026. Verfasst von Maryam Tariq und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Child and Adolescent Psychiatry, The University of Kansas Medical Center, Overland Park, Kansas, USA. Die Arbeit nennt 7 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Child and Adolescent Psychiatry, The University of Kansas Medical Center, Overland Park, Kansas, USA.

ORCID-Profile: Maryam Tariq

Zitieren

APA

Tariq, M., & Genovese, A. (2026). Letter: Clonidine Hydrochloride Extended-Release Oral Suspension for Pediatric Attention-Deficit/Hyperactivity Disorder: A Meaningful Addition to Clinical Practice?. Journal of Child and Adolescent Psychopharmacology, 36(6), 384-385. https://doi.org/10.1177/10445463261454151

Vancouver

Tariq M, Genovese A. Letter: Clonidine Hydrochloride Extended-Release Oral Suspension for Pediatric Attention-Deficit/Hyperactivity Disorder: A Meaningful Addition to Clinical Practice?. Journal of Child and Adolescent Psychopharmacology. 2026;36(6):384-385. doi:10.1177/10445463261454151

BibTeX
@article{Tariq2026,
  author = {Tariq, Maryam and Genovese, Ann},
  title = {Letter: Clonidine Hydrochloride Extended-Release Oral Suspension for Pediatric Attention-Deficit/Hyperactivity Disorder: A Meaningful Addition to Clinical Practice?},
  journal = {Journal of Child and Adolescent Psychopharmacology},
  year = {2026},
  volume = {36},
  number = {6},
  pages = {384--385},
  doi = {10.1177/10445463261454151}
}
Kostenlos starten →